American Century Companies Inc. decreased its holdings in shares of Waters Co. (NYSE:WAT) by 52.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 244,225 shares of the medical instruments supplier’s stock after selling 268,674 shares during the quarter. American Century Companies Inc. owned approximately 0.31% of Waters worth $47,182,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in WAT. Harding Loevner LP increased its stake in shares of Waters by 207.1% during the 3rd quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock worth $158,275,000 after purchasing an additional 1,866,848 shares during the last quarter. Koch Industries Inc. grew its stake in Waters by 36,932.0% in the 2nd quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock valued at $532,000 after buying an additional 533,298 shares during the last quarter. Mackenzie Financial Corp grew its stake in Waters by 157.5% in the 3rd quarter. Mackenzie Financial Corp now owns 651,400 shares of the medical instruments supplier’s stock valued at $116,939,000 after buying an additional 398,438 shares during the last quarter. Pictet Asset Management Ltd. grew its stake in Waters by 57.9% in the 3rd quarter. Pictet Asset Management Ltd. now owns 340,478 shares of the medical instruments supplier’s stock valued at $61,123,000 after buying an additional 124,800 shares during the last quarter. Finally, First Trust Advisors LP grew its stake in Waters by 255.5% in the 3rd quarter. First Trust Advisors LP now owns 170,217 shares of the medical instruments supplier’s stock valued at $30,557,000 after buying an additional 122,339 shares during the last quarter. Institutional investors own 91.88% of the company’s stock.
A number of research analysts recently issued reports on the stock. BTIG Research reiterated a “buy” rating on shares of Waters in a research note on Thursday, January 25th. William Blair reiterated an “outperform” rating on shares of Waters in a research note on Tuesday, January 23rd. Citigroup raised their target price on shares of Waters from $190.00 to $223.00 and gave the company a “neutral” rating in a research note on Wednesday, January 24th. Robert W. Baird raised their target price on shares of Waters from $219.00 to $220.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Finally, JPMorgan Chase & Co. raised their target price on shares of Waters from $180.00 to $200.00 and gave the company a “neutral” rating in a research note on Wednesday, January 24th. Twelve analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $203.75.
In other Waters news, Director William J. Miller sold 3,500 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total value of $682,290.00. Following the sale, the director now directly owns 25,849 shares in the company, valued at approximately $5,039,004.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Eugene G. Cassis sold 23,863 shares of the firm’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $197.53, for a total transaction of $4,713,658.39. Following the completion of the sale, the senior vice president now owns 15,100 shares in the company, valued at $2,982,703. The disclosure for this sale can be found here. Insiders sold a total of 124,789 shares of company stock worth $26,083,647 over the last 90 days. Company insiders own 5.07% of the company’s stock.
Shares of Waters Co. (NYSE WAT) opened at $193.59 on Monday. The company has a quick ratio of 1.97, a current ratio of 2.10 and a debt-to-equity ratio of 0.66. The stock has a market cap of $15,400.00, a price-to-earnings ratio of 1,075.50, a price-to-earnings-growth ratio of 2.32 and a beta of 0.88. Waters Co. has a 12-month low of $148.14 and a 12-month high of $220.20.
Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.07. The company had revenue of $687.28 million for the quarter, compared to analyst estimates of $671.98 million. Waters had a net margin of 0.88% and a return on equity of 24.70%. The business’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period last year, the business posted $2.21 EPS. sell-side analysts predict that Waters Co. will post 8.16 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/12/american-century-companies-inc-has-47-18-million-stake-in-waters-co-wat.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.